Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling

Mol Cell Biol. 2007 Dec;27(24):8658-69. doi: 10.1128/MCB.00985-07. Epub 2007 Oct 15.

Abstract

Hormone-dependent transactivation by several of the steroid hormone receptors is potentiated by the Hsp90-associated cochaperone FKBP52, although not by the closely related FKBP51. Here we analyze the mechanisms of potentiation and the functional differences between FKBP51 and FKBP52. While both have peptidyl-prolyl isomerase activity, this is not required for potentiation, as mutations abolishing isomerase activity did not affect potentiation. Genetic selection in Saccharomyces cerevisiae for gain of potentiation activity in a library of randomly mutated FKBP51 genes identified a single residue at position 119 in the N-terminal FK1 domain as being a critical difference between these two proteins. In both the yeast model and mammalian cells, the FKBP51 mutation L119P, which is located in a hairpin loop overhanging the catalytic pocket and introduces the proline found in FKBP52, conferred significant potentiation activity, whereas the converse P119L mutation in FKBP52 decreased potentiation. A second residue in this loop, A116, also influences potentiation levels; in fact, the FKBP51-A116V L119P double mutant potentiated hormone signaling as well as wild-type FKBP52 did. These results suggest that the FK1 domain, and in particular the loop overhanging the catalytic pocket, is critically involved in receptor interactions and receptor activity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Catalysis
  • Drug Synergism
  • Mice
  • Models, Molecular
  • Molecular Sequence Data
  • Mutant Proteins / isolation & purification
  • Mutant Proteins / metabolism
  • Mutation / genetics
  • Peptidylprolyl Isomerase / chemistry*
  • Protein Structure, Tertiary
  • Recombinant Fusion Proteins / metabolism
  • Selection, Genetic
  • Signal Transduction / drug effects*
  • Steroids / pharmacology*
  • Structure-Activity Relationship
  • Tacrolimus Binding Proteins / chemistry*
  • Tacrolimus Binding Proteins / metabolism*

Substances

  • Mutant Proteins
  • Recombinant Fusion Proteins
  • Steroids
  • Tacrolimus Binding Proteins
  • tacrolimus binding protein 4
  • Peptidylprolyl Isomerase
  • tacrolimus binding protein 5